Femme et Homme
- | Pays :
- Hungary
- United Kingdom
- Poland
- Les 5 autres...
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is to evaluate the efficacy, safety, and tolerability of 4 daily doses of RWJ-333369 as adjunctive treatment of refractory partial epilepsy in subjects who are between 18 and 70 years of age, inclusive
Critère d'inclusion
- Refractory Epilepsy